Search Site

Andrew J. Westwood,
MD

Assistant Professor of Neurology at CUMC

Dr. Westwood completed his neuroscience and medical training at Cambridge University in the United Kingdom. He was a resident in Neurology at Boston University Medical Center, where he also completed an accredited fellowship in Sleep Medicine. He has joined the Division of Epilepsy and the Sleep Disorders Center in the Department of Neurology as the first full-time sleep specialist. Apart from his interest in the care of patients with sleep disorders, Dr. Westwood has a particular interest in behavioral neurology and neurodegenerative diseases. In addition to being a Diplomate of the Royal College of Physicians in the UK, with a special certification in Neurology, Dr. Westwood is a member of the American Academy of Neurology and American Academy of Sleep Medicine. Diagnostics include polysomnography (in-lab and ambulatory with/without extended EEG montage), actigraphy, multiple sleep latency testing, and maintenance of wakefulness testing.

Dr. Westwood has a strong interest in behavioral neurology with a particular interest in the relationship of sleep and neurodegenerative disorders. During medical school he worked with Dr. Goedert and Dr. Spillantini at Cambridge University, using an animal model of frontotemporal dementia. Dr. Westwood went on to work on the relationship of anxiety in aphasia with Dr. Martin Albert, Director of the Harold Goodglass Aphasia Research Center, and Dr. Cahana-Amitay. He has undertaken projects in neuroepidemiology in the Framingham Heart Study under the mentorship of Dr. Sudha Seshadri. These have included the relationship of insulin-like growth factor-1 and Alzheimer's disease, as well as sleep duration and development of dementia. In addition to clinical research, Dr. Westwood also has a strong interest in clinical teaching.

NIH Grants

AN OPEN LABEL EXPANDED ACCESS PROGRAM INTENDED TO PROVIDE TREATMENT WITH HBS-101 (PITOLISANT) TO ADULT PATIENTS IN THE U.S. WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY WITH OR WITHOUT CATAPLEXY (P&S Industry Clinical Trial)